Showing results (271-280 of 571) with videos related to
Sort By:
Pageof 58
Circulation. Cardiovascular Interventions|January 2, 2015
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary interventionGuido Parodi, Benedetta Bellandi, Ioanna Xanthopoulou, et al.Scientifica|May 31, 2016
Assessing Risk in Patients with Stable Coronary Disease: When Should We Intensify Care and Follow-Up? Results from a Meta-Analysis of Observational Studies of the COURAGE and FAME EraUmberto Barbero, Fabrizio D'Ascenzo, Freek Nijhoff, et al.International Journal of Cardiology|June 16, 2018
Transcatheter or surgical treatment of severe aortic stenosis and coronary artery disease: A comparative analysis from the Italian OBSERVANT studyMarco Barbanti, Sergio Buccheri, Davide Capodanno, et al.Journal of the American Heart Association|October 9, 2025
Validation of the Mayo Clinic Percutaneous Coronary Intervention Risk Prediction Score in Patients With Acute Coronary SyndromeAntonio Landi, Andrea Zito, Mandeep Singh, et al.Circulation. Cardiovascular Interventions|September 23, 2010
Pharmacodynamic effects of concomitant versus staggered clopidogrel and omeprazole intake: results of a prospective randomized crossover studyJosé L Ferreiro, Masafumi Ueno, Davide Capodanno, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|December 11, 2013
The SYNTAX score does not predict presence of carotid disease in a multivessel coronary disease populationLuca Costanzo, Maria Barbara Campisano, Davide Capodanno, et al.The American Journal of Cardiology|August 3, 2012
Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry)Davide Capodanno, Anna Caggegi, Piera Capranzano, et al.JACC. Cardiovascular Interventions|August 13, 2025
Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary SyndromesClaudio Laudani, Daniele Giacoppo, Giovanni Occhipinti, et al.European Heart Journal|December 7, 2020
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trialsDaniele Giacoppo, Yuji Matsuda, Luca Nai Fovino, et al.European Heart Journal. Cardiovascular Pharmacotherapy|November 25, 2022
Dual antiplatelet therapy duration after percutaneous coronary intervention in patients with indication to oral anticoagulant therapy. A systematic review and meta-analysis of randomized controlled trialsClaudio Montalto, Francesco Costa, Sergio Leonardi, et al.Pageof 58